October 2026 — New site and platform summary
Bioceuticals.AI replaces its 2023 site with a platform summary, evidence pages and the EBV program description. The investor deck is available on request.
News
Notes from the platform
Announcements, publications and talks. Older items from the previous site are being re-indexed here.
2026
Recent
2025 — Stanford: EBV-infected B cells drive lupus
Younis et al., Science Translational Medicine (2025); Stanford Medicine news release, Nov 12, 2025. The finding that set the EBV program's first target.
Archive — CymaScope and cell language
Dr. Ji's work with the CymaScope on cymatics and cellular signalling is archived at humanrnaproject.com.